Yoko Matsuda Selected Research

Histones (Histone)

3/2019	Citrullinated histone H3 expression in anti-neutrophil cytoplasmic antibody-associated vasculitis in older Japanese autopsy patients.
8/2016	Presence of Citrullinated Histone H3-Positive Neutrophils in Microscopic Polyangiitis from the Early Phase: An Autopsy Proven Case.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoko Matsuda Research Topics

Disease

65	Neoplasms (Cancer) 01/2023 - 01/2005
33	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 12/2008
28	Adenocarcinoma 01/2023 - 05/2005
19	Carcinogenesis 02/2022 - 05/2005
17	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2011
11	Colorectal Neoplasms (Colorectal Cancer) 02/2023 - 10/2007
8	Melanoma (Melanoma, Malignant) 03/2020 - 06/2010
5	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2007
5	Body Weight (Weight, Body) 03/2021 - 03/2006
5	Carcinoma (Carcinomatosis) 01/2021 - 10/2007
5	Fibrosis (Cirrhosis) 01/2020 - 12/2015
5	Adenoma (Adenomas) 01/2020 - 10/2007
5	Prostatic Neoplasms (Prostate Cancer) 01/2018 - 01/2011
4	Inflammation (Inflammations) 02/2022 - 01/2020
4	Glioma (Gliomas) 02/2015 - 07/2011
4	Glioblastoma (Glioblastoma Multiforme) 02/2015 - 01/2011
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015 - 02/2010
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2014 - 07/2007
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2008
3	Stomach Neoplasms (Stomach Cancer) 02/2020 - 09/2017
3	Brain Ischemia (Cerebral Ischemia) 01/2015 - 09/2013
3	Adenocarcinoma of Lung 04/2014 - 12/2008
2	Colonic Neoplasms (Colon Cancer) 02/2023 - 05/2022
2	Adenosquamous Carcinoma 01/2022 - 10/2012
2	Triple Negative Breast Neoplasms 05/2021 - 01/2021
2	Metaplasia 01/2021 - 04/2014
2	Diabetes Mellitus 01/2020 - 01/2020
2	Residual Neoplasm 11/2019 - 03/2018
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 03/2019 - 06/2016
2	Immunoglobulin G4-Related Disease 06/2016 - 12/2015
2	Reperfusion Injury 01/2015 - 09/2013
2	Bowen's Disease (Disease, Bowen) 08/2014 - 12/2013
2	Actinic Keratosis 08/2014 - 12/2013
2	Uterine Cervical Dysplasia 08/2012 - 02/2010
2	Hyperplasia 07/2009 - 09/2008

Drug/Important Bio-Agent (IBA)

23	NestinIBA 01/2021 - 01/2011
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2007
9	Messenger RNA (mRNA)IBA 06/2016 - 03/2006
8	Small Interfering RNA (siRNA)IBA 01/2021 - 03/2011
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2015
7	CarbohydratesIBA 01/2023 - 09/2017
7	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 09/2014 - 02/2010
5	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2011
5	Protein Isoforms (Isoforms)IBA 09/2014 - 02/2010
5	LumicanIBA 08/2014 - 12/2008
4	Estrogen ReceptorsIBA 02/2023 - 12/2008
4	SulfotransferasesIBA 01/2023 - 04/2018
4	AntigensIBA 01/2021 - 09/2017
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 09/2012 - 02/2010
4	Methoxsalen (Oxsoralen)FDA Link 07/2009 - 03/2006
4	4- (N- methyl- N- nitrosamino)- 1- (3- pyridyl)- 1- butanoneIBA 07/2009 - 03/2006
3	Proteoglycans (Proteoglycan)IBA 01/2023 - 10/2019
3	EnzymesIBA 01/2023 - 03/2006
3	STNM01IBA 01/2023 - 04/2018
3	OligonucleotidesIBA 01/2023 - 04/2018
3	CytokinesIBA 02/2022 - 01/2005
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 01/2020
3	Monoclonal AntibodiesIBA 01/2022 - 09/2012
3	ParaffinIBA 01/2022 - 01/2011
3	Carcinoembryonic AntigenIBA 12/2021 - 09/2017
3	Eosine Yellowish-(YS) (Eosin)IBA 11/2019 - 01/2016
3	Peroxidase (Myeloperoxidase)IBA 11/2019 - 06/2016
3	Gemcitabine FDA Link 01/2019 - 01/2016
3	H19 long non-coding RNAIBA 10/2018 - 01/2018
3	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 09/2014 - 01/2012
3	QuinoxalinesIBA 03/2010 - 09/2009
2	Estrogens (Estrogen)FDA Link 02/2023 - 05/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2013
2	Formaldehyde (Formol)FDA Link 01/2022 - 01/2011
2	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 09/2017
2	Threonine (L-Threonine)FDA Link 01/2022 - 01/2020
2	Keratins (Keratin)IBA 12/2021 - 01/2005
2	CarcinogensIBA 06/2021 - 03/2010
2	VimentinIBA 01/2021 - 01/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2020 - 01/2017
2	N-acetyltalosaminuronic acid (NAT)IBA 11/2019 - 01/2019
2	Hematoxylin (Haematoxylon)IBA 10/2019 - 01/2016
2	Double-Stranded RNA (RNA, Double Stranded)IBA 10/2019 - 04/2018
2	Histones (Histone)IBA 03/2019 - 08/2016
2	Long Noncoding RNAIBA 10/2018 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 08/2018 - 04/2018
2	AndrogensIBA 01/2017 - 06/2005
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 08/2016 - 06/2016
2	Fixatives (Pickling Agents)IBA 01/2015 - 01/2011
2	Xanthine DehydrogenaseIBA 01/2015 - 01/2015
2	paraform (paraformaldehyde)IBA 01/2015 - 01/2011
2	Cytoskeletal ProteinsIBA 05/2011 - 12/2010
2	NitrosaminesIBA 10/2007 - 07/2007
2	Tumor Viral Antigens (Large T Antigen)IBA 06/2005 - 05/2005
2	probasinIBA 06/2005 - 05/2005
1	Adenine FDA LinkGeneric 02/2023
1	CytosineIBA 02/2023
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2023
1	Granzymes (Granzyme)IBA 01/2023

Therapy/Procedure

12	Therapeutics 01/2023 - 02/2010
7	Neoadjuvant Therapy 01/2022 - 03/2018
6	Drug Therapy (Chemotherapy) 01/2023 - 02/2018
2	Pancreatectomy 01/2022 - 01/2019
2	Molecular Targeted Therapy 01/2013 - 07/2011
1	Immunotherapy 01/2023